Poniard Pharmaceuticals: Clinical Trials

5 trials sponsored by Poniard Pharmaceuticals, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 unknown, 1 terminated. 5 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Unknown 2, Terminated 1
Phase 14Unknown 2, Completed 1, Terminated 1

Follow Poniard Pharmaceuticals: new trials by email

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer
Picoplatin, docetaxel - Hormone Refractory Prostate Cancer
Phase 1 / Phase 2UnknownPoniard Pharmaceuticals952006-06-012009-01-21
A Study of Picoplatin in Colorectal Cancer
(FOLPI) Picoplatin with 5-FU and Leucovorin, FOLPI, FOLFOX - Colorectal Cancer
Phase 1 / Phase 2UnknownPoniard Pharmaceuticals432006-04-012009-01-21
Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer
picoplatin - Small Cell Lung Cancer
Phase 2CompletedPoniard Pharmaceuticals752005-06-012009-01-21
A Trial of Skeletal Targeted Radiotherapy Using Holmium-166-DOTMP in Patients With Multiple Myeloma
Holmium-166-DOTMP - Multiple Myeloma
Phase 1 / Phase 2TerminatedPoniard Pharmaceuticals2002-03-012009-01-21
Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
melphalan, peripheral blood stem cell transplantation, holmium Ho 166 DOTMP - Multiple Myeloma and Plasma Cell Neoplasm
Phase 1 / Phase 2CompletedPoniard Pharmaceuticals2002-01-012009-04-03

Conditions studied

Multiple Myeloma (2)  ·  Colorectal Neoplasms (1)  ·  Hypersensitivity (1)  ·  Neoplasm Metastasis (1)  ·  Neoplasms, Plasma Cell (1)  ·  Prostatic Neoplasms (1)  ·  Recurrence (1)  ·  Small Cell Lung Carcinoma (1)

Interventions

amminedichloro(2-methylpyridine)platinum(II) (3)  ·  holmium-1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetrakis(methylenephosphonic acid) (2)  ·  Docetaxel (1)  ·  Fluorouracil (1)  ·  Folfox protocol (1)  ·  Leucovorin (1)  ·  Melphalan (1)  ·  Peripheral Blood Stem Cell Transplantation (1)

Countries

Russia (3)  ·  United States (2)  ·  Canada (1)

Top investigators

David Karlin, MD (1)  ·  Hazel Breitz, MD (1)  ·  Paul Weiden, MD (1)  ·  Robert Earhart, MD (1)  ·  Robert Earhart, MD, PhD (1)  ·  Wendy Jenkins (1)